Semax
Focus, memory and stroke recovery. Developed in Russia and used there as a medicine.
This page has not yet been reviewed by a credentialed medical professional. It is educational and is not medical advice.
Semax: key facts
- Evidence level Human trials
- Approved as a medicineYes: Approved in Russia; not authorized in the US or Canada
- Randomized trials on PubMed1
- Papers on PubMed208
- Trials testing it (ClinicalTrials.gov)None found
- In tested sportCheck the current WADA Prohibited List
In one sentence: Semax is an approved medicine in some form (approved in Russia; not authorized in the US or Canada). Its strongest evidence is human trials, with 1 randomized trial on PubMed that mention it.
Human studies exist, mostly from Russia and of mixed quality. Not approved in the US or Canada.
Key studies
Randomized trials Listed on PubMed as randomized trials that mention it. Some only measure it rather than test it as a treatment.
Reviews Summaries of other studies.
Other notable papers The most relevant other papers on PubMed.
See its full evidence profile and newest papers →
Clinical trials
That usually means it hasn't been properly tested in people.
Where it fits
Common questions
Is Semax approved?
Approved in Russia; not authorized in the US or Canada.
Has Semax been tested in people?
1 randomized trial on PubMed mention it. Human studies exist, mostly from Russia and of mixed quality. Not approved in the US or Canada.
Is Semax allowed in sport?
Check the current WADA Prohibited List; unapproved substances can be banned under its catch-all category.
This is a short, data-driven profile. Study and trial lists come from PubMed and ClinicalTrials.gov and are refreshed periodically. "What people use it for" describes common claims, not recommendations. Educational only, not medical advice.
